DASA ON receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Diagnosticos da America SA (DASA3)
The Diag America share price today is 3.26, view BVMF DASA3 stock exchange data. Track the latest Diag America share price with real-time updates on DASA3 stock performance including market cap, day range, 52-week range and dividend yield. Access DASA3 charts, earnings dates and analyst estimates to support your investment decisions.
3.26
+0.31(+10.51%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.02
3.58
52 wk Range
1.88
5.79
DASA3 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.023.58
52 wk Range
1.885.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DASA3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.97
Upside
+21.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
4 Buy
8 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.97
(+21.68% Upside)
Diagnosticos da America SA Earnings Call Summary for Q2/2026
- DASA posted Q2 2026 adjusted EPS of -$0.04 vs. -$0.37 forecast, but revenue of $2.22B missed estimates by 5.53%, sending shares down 16.73%.
- Consolidated EBITDA surged 53% YoY to BRL 446M with margin expanding to 21%; free cash flow turned positive at BRL 292M from negative BRL 18M prior year.
- Gross margin fell 1.6pp sequentially to 33.2% due to accounting changes and new equipment ramp-up, though management expects pressure to ease over time.
- Company prioritizes deleveraging through EBITDA growth and completed BRL 700M debenture issuance in July to refinance short-term debt and extend maturities.
- Management expects continued growth from premium care, home care, and B2B services, with July showing recovery from Q2 seasonal weakness; analysts forecast profitability in FY2026.
Last Updated: 14-08-2026, 11:26 pm
Read Full TranscriptEarnings
Latest Release
05-11-2026
EPS / Forecast
0.05 / 0.01
Revenue / Forecast
2.39B / 2.4B
Compare DASA3 to Peers and Sector
Metrics to compare | DASA3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDASA3PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | 10.5x | −0.2x | |
PEG Ratio | −0.42 | 0.10 | 0.00 | |
Price/Book | 0.5x | 1.1x | 2.6x | |
Price / LTM Sales | 0.4x | 0.6x | 2.8x | |
Upside (Analyst Target) | 21.7% | 45.3% | 65.6% | |
Fair Value Upside | Unlock | 24.2% | 10.0% | Unlock |
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Diag America (DASA3) Share Price Today?
The Diag America share price today is 3.26.
What is the current Diag America (DASA3) share price and day range?
As of 07-11-2026, the Diag America share price is 3.26, with a previous close of 3.26. The share price has ranged from 3.02 to 3.58 today, while the 52-week range spans from 1.88 to 5.79.
What Is the Diag America Market Cap?
As of today, Diag America market cap is 3.69B.
What Is the Diag America (DASA3) Share Price Target?
The average 12-month share price target for Diag America is 3.97, with a high estimate of 5.5 and a low estimate of 2.5. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +21.68% Upside potential.
What Is Diag America's Earnings Per Share (TTM)?
The Diag America EPS (TTM) is -0.71.
When Is the Next Diag America Earnings Date?
Diag America will release its next earnings report on 31-03-2027.
From a Technical Analysis Perspective, Is DASA3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Diag America Trade On?
Diag America is listed and trades on the B3 Stock Exchange.
What Is the Stock Symbol for Diag America?
The stock symbol for Diag America is "DASA3."
How Many Times Has Diag America Stock Split?
Diag America has split 2 times.
How Many Employees Does Diag America Have?
Diag America has 26255 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.